Erratum: Antibiotics and probiotics in inflammatory bowel disease: When to use them? (Frontline Gastroenterology (2020) 11 (62–69) DOI: 10.1136/flgastro-2018-101057)

Research output: Contribution to journalComment/debate

Abstract

A number of studies cited in this paper assessed a probiotic formulation previously known as VSL#3. The probiotic formulation that was assessed in these studies is now known by the generic name 'De Simone Formulation'. The current product known as VSL#3 is not the same formulation as the De Simone Formulation. The De Simone Formulation is available under the brand names Visbiome (USA) and Vivomixx (Europe). doi: 10.1136/flgastro-2018-100617.

Original languageEnglish (US)
Pages (from-to)E1
JournalFrontline Gastroenterology
Volume11
Issue number3
DOIs
StatePublished - May 1 2020

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Fingerprint Dive into the research topics of 'Erratum: Antibiotics and probiotics in inflammatory bowel disease: When to use them? (Frontline Gastroenterology (2020) 11 (62–69) DOI: 10.1136/flgastro-2018-101057)'. Together they form a unique fingerprint.

  • Cite this